Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Rating of "Buy" from Brokerages

Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) has been given a consensus recommendation of "Buy" by the six analysts that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $41.25.

Several equities research analysts recently commented on the stock. JMP Securities restated a "market perform" rating on shares of Simulations Plus in a research report on Wednesday, June 18th. William Blair reiterated an "outperform" rating on shares of Simulations Plus in a report on Tuesday, June 3rd. Craig Hallum reduced their price objective on Simulations Plus from $45.00 to $36.00 and set a "buy" rating for the company in a research note on Friday, June 13th. Wall Street Zen upgraded Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. Finally, KeyCorp upped their target price on Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a report on Wednesday, April 16th.

Insider Transactions at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $33.51, for a total transaction of $670,200.00. Following the completion of the transaction, the director owned 3,344,157 shares of the company's stock, valued at approximately $112,062,701.07. The trade was a 0.59% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 19.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Simulations Plus

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Jones Financial Companies Lllp boosted its position in shares of Simulations Plus by 53.6% during the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock valued at $34,000 after acquiring an additional 427 shares in the last quarter. Johnson Financial Group Inc. acquired a new position in Simulations Plus during the fourth quarter worth $39,000. Fifth Third Bancorp boosted its stake in shares of Simulations Plus by 33.8% in the 1st quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company's stock valued at $36,000 after purchasing an additional 375 shares in the last quarter. Tower Research Capital LLC TRC grew its holdings in shares of Simulations Plus by 42.2% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock worth $72,000 after purchasing an additional 764 shares during the last quarter. Finally, AlphaQuest LLC increased its position in shares of Simulations Plus by 502.9% during the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock worth $75,000 after purchasing an additional 2,243 shares in the last quarter. Institutional investors own 78.08% of the company's stock.

Simulations Plus Stock Down 1.7%

NASDAQ:SLP traded down $0.31 during trading hours on Tuesday, reaching $18.01. 20,738 shares of the company's stock were exchanged, compared to its average volume of 258,183. The company has a market capitalization of $362.18 million, a P/E ratio of 51.45 and a beta of 0.83. Simulations Plus has a 12 month low of $16.72 and a 12 month high of $47.91. The business's 50-day simple moving average is $27.52 and its two-hundred day simple moving average is $29.01.

Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.06. The company had revenue of $22.43 million during the quarter, compared to the consensus estimate of $21.93 million. Simulations Plus had a return on equity of 7.86% and a net margin of 9.18%. The company's quarterly revenue was up 22.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.20 EPS. As a group, sell-side analysts anticipate that Simulations Plus will post 1.09 earnings per share for the current fiscal year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.